(Q37715012)

22 August 2017

1 reference

title

Chapter 12- Brain as an HIV sequestered site: Use of nanoparticles as a therapeutic option (English)

1 reference

22 August 2017

0 references

1

Christopher J Destache

1 reference

22 August 2017

publication date

8 December 2009

1 reference

Progress in Brain Research

22 August 2017

published in

1 reference

22 August 2017

volume

180

1 reference

22 August 2017

page(s)

225-233

1 reference

Updated research nosology for HIV-associated neurocognitive disorders

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Quantitative assessment of HIV-1 protease inhibitor interactions with drug efflux transporters in the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Transport of human immunodeficiency virus type 1 pseudoviruses across the blood-brain barrier: role of envelope proteins and adsorptive endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

The challenge of viral reservoirs in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Nanoparticles in cancer therapy and diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Multidrug resistance-associated proteins: expression and function in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Changing incidence of central nervous system diseases in the EuroSIDA cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Biomedical applications of nanotechnology--implications for drug targeting and gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Combination antiretroviral drugs in PLGA nanoparticle for HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Second-line chemotherapy with the association of liposomal daunorubicin, carboplatin and etoposide in children with recurrent malignant brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) on pharmacokinetics and central nervous system penetration of abacavir and zidovudine in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Human immunodeficiency virus I-induced expression of P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Two phases of HIV RNA decay in CSF during initial days of multidrug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

HIV-Tat protein induces P-glycoprotein expression in brain microvascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Nanotechnology: a focus on nanoparticles as a drug delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

High intratumoral accumulation of stealth liposomal doxorubicin in sarcomas--rationale for combination with radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

HIV dementia: an evolving disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

P-glycoprotein and mutlidrug resistance-associated proteins limit the brain uptake of saquinavir in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Induction of P-glycoprotein expression and activity by ritonavir in bovine brain microvessel endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Direct plasmid mediated transfection of adult murine brain cells in vivo using cationic liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

HIV infection and dementia in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

Pain and the blood-brain barrier: obstacles to drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980012-X

7 January 2021

10.1016/S0079-6123(08)80012-X

Identifiers

DOI

1 reference

22 August 2017

1 reference